20 news items
Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
TEVA
4 Jun 24
-defying portfolio, harnessing our generics expertise and stepping up innovation to continue the momentum behind the discovery, delivery, and expanded
New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)
TEVA
1 Jun 24
.
"UZEDY is a long-acting formulation of risperidone with an innovative delivery system that requires no loading dose
Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024
TEVA
1 Jun 24
with a category-defying portfolio, harnessing our generics expertise and stepping up innovation to continue the momentum behind the discovery, delivery
4 Analysts Assess Teva Pharmaceutical Indus: What You Need To Know
TEVA
30 May 24
, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system
Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)
TEVA
29 May 24
and HD chorea treat these chronic, involuntary movements," said Dell Faulkingham, Senior Vice President, Head of U.S. Innovative Medicines at Teva
vr3vtr4kx8qqz9vhiapqix6t1v72y6wnajc78tb6xyxv
TEVA
22 May 24
has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo
i3o6u3n9ryzn46m2evzmdg1i2n2df2yjpwz3za0
ALVO
TEVA
20 May 24
portfolio, harnessing our generics expertise and stepping up innovation to continue the momentum behind the discovery, delivery, and expanded
0ukwdyjq9sysvd20unoczjy 92m4qc4k8i007kst1ung7gnq0wkn1
ABBV
AMGN
CURLF
18 May 24
in innovative treatments like
za5vwb1ko34pv6kq0efky53pq8f2m0fkof5wzyqt7wg3vrh
TEVA
15 May 24
expertise and stepping up innovation to continue the momentum behind the discovery, delivery, and expanded development of modern medicine. For over 120
e4d077sk36vc9kqrxekgnp0mkr95p32e5imk3poe4msmk
TEVA
8 May 24
business across all regions, and continued growth of our innovative brands AUSTEDO and AJOVY."
Mr
7hfc6p7qm
TEVA
8 May 24
long-acting treatment option for schizophrenia and further show our dedication to advancing innovative science in mental health and beyond," said
hwmmpvej0oxq893hkbinskmu4tl46xcgbl
TEVA
2 May 24
with a category-defying portfolio, harnessing our generics expertise and stepping up innovation to continue the momentum behind the discovery, delivery
m4pcv 9n8x3o
TEVA
2 May 24
and stepping up innovation to continue the momentum behind the discovery, delivery, and expanded development of modern medicine. For over 120 years
w3lvyk2kjxznjd8 mz4rj7ei4vpvp1
AMPH
AZN
NVO
1 May 24
, the FTC is fighting these illegal tactics and making sure that Americans can get timely access to innovative and affordable versions
1gs5l9g5y498e2k7b0t931ca88vw0gw5bh
ALVO
TEVA
30 Apr 24
. (NYSE and TASE: TEVA) is a global pharmaceutical leader with a category-defying portfolio, harnessing our generics expertise and stepping up innovation
qcxgzs 0m32hl34cug1nx1mjuymvc1gb7etnfqsriz0l
TEVA
VNDA
22 Apr 24
incentives are crucial for innovators to invest the billions required to develop new, successful treatments."
v9l742b46a0ti9rth92jf9zpih2tgc30zvhyf499feidmwcx3fw60d
TEVA
11 Apr 24
and Teva is committed to research on a global scale that helps address unmet need where it exists and ensure that the role of treatment innovations like
rnut0d52h5n07qr9f05pw0wbn8wcpb12et5 j2x5e9k3xu
TEVA
9 Apr 24
pharmaceutical leader with a category-defying portfolio, harnessing our generics expertise and stepping up innovation to continue the momentum behind
ksgj2cqp0ntjp0qlw0x kg43
TEVA
6 Apr 24
.
"As part of Teva's commitment to advancing treatment innovation for schizophrenia patients, this research provides clinical insights into how healthcare
nek0ttrr6emryll5041w7i9nvbx1n2niopv102n29
TEVA
4 Apr 24
, harnessing our generics expertise and stepping up innovation to continue the momentum behind the discovery, delivery, and expanded development
- Prev
- 1
- Next